Veradermics, Incorporated Share Price & Technical Analysis
MANE · $101.6 (-2.94%)
Healthcare / Biotechnology
$101.6
-2.94%
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in th…
Price chart
Seasonality
May has 1 positive and 0 negative years (last 1 years shown)
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | – | 39% | 34% | 52% | 6% | – | – | – | – | – | – | – | 131% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Emerging · Uptrend
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was incorporated in 2019 and is headquartered in New Haven, Connecticut.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$4.47B
P/E ratio
—
52W high
$117.7
52W low
$32.00
Volume
2,36,925
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Veradermics, Incorporated share price today?
- Veradermics, Incorporated (MANE) last traded around $101.6 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MANE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MANE. Download the app for real-time alerts.
- How can I analyze Veradermics, Incorporated stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.